AltheaDx
Castle Biosciences to Acquire AltheaDx for $65M
Castle said the move furthers its mid- and long-term growth plans with a strategic advance into pharmacogenomics and mental health.
Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More
A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.
AltheaDx Closes $27M Series D Round
The financing, which comes on the heels of a $30 million Series C round, will be used for operating capital.
AltheaDx Closes $30M Series C Financing Round
The funding comes several months after the drug metabolism testing company withdrew a planned $74.3 million initial public offering.
Aug 11, 2015
AltheaDx, Sinfonia Partner on Mental Health
Mar 9, 2015
AltheaDx Withdraws IPO
Dec 23, 2014
MDx Firm AltheaDx Files for $69M IPO
Sep 29, 2014
NYDOH Approves AltheaDx's PGx Test Suite
Jul 21, 2014
AltheaDx Receives CAP Accreditation
Feb 6, 2012
AltheaDx Named Ion Torrent CSP
Jul 6, 2011
Apr 13, 2010